A 58-year-old man from Delhi presents to the emergency department with a 7-day history of fever, cough, and dyspnea. He is a known diabetic and hypertensive on regular medications. On examination, SpO₂ is 88% on room air, respiratory rate 28/min, and bilateral crackles are heard on auscultation. Chest X-ray shows bilateral ground-glass opacities with a peripheral and lower lobe predominance. RT-PCR for SARS-CoV-2 is positive. His D-dimer is elevated at 2.8 μg/mL (normal

Question

A 58-year-old man from Delhi presents to the emergency department with a 7-day history of fever, cough, and dyspnea. He is a known diabetic and hypertensive on regular medications. On examination, SpO₂ is 88% on room air, respiratory rate 28/min, and bilateral crackles are heard on auscultation. Chest X-ray shows bilateral ground-glass opacities with a peripheral and lower lobe predominance. RT-PCR for SARS-CoV-2 is positive. His D-dimer is elevated at 2.8 μg/mL (normal <0.5), and ferritin is 680 ng/mL. Which of the following best explains the pathophysiology of severe COVID-19 in this patient?

Accepted Answer

B. Uncontrolled viral replication leading to direct cytotoxic injury of alveolar epithelium and endothelium, triggering a hyperinflammatory response with elevated IL-6, TNF-α, and IL-1β. ## Pathophysiology of Severe COVID-19

**Key Point:** Severe COVID-19 is characterized by a biphasic disease course: an initial viral replication phase (days 1–7) followed by a hyperinflammatory phase (days 7–14) driven by dysregulated innate immunity, not by bacterial superinfection or primary cardiac events.

### Mechanism of Severe Disease

SARS-CoV-2 binds to ACE2 receptors on alveolar epithelial cells and pulmonary endothelial cells, causing:

1. **Direct viral cytotoxicity** — syncytia formation, apoptosis, and necrosis of respiratory epithelium
2. **Endothelial dysfunction** — increased vascular permeability, loss of barrier function, and microvascular thrombosis
3. **Hyperinflammatory cascade** — massive release of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, IFN-γ) by infected macrophages and dendritic cells
4. **Coagulopathy** — tissue factor expression, platelet activation, and complement cascade activation leading to thrombosis (explaining elevated D-dimer)

### Clinical Correlates in This Case

| Finding | Mechanism |
|---------|----------|
| Bilateral ground-glass opacities | Alveolar edema from increased capillary permeability and direct epithelial injury |
| Elevated D-dimer (2.8 μg/mL) | Microvascular thrombosis and fibrinolysis from endothelial dysfunction |
| Elevated ferritin (680 ng/mL) | Marker of macrophage activation and cytokine storm |
| Day 7 presentation with hypoxia | Transition from viral replication to hyperinflammatory phase |
| Comorbidities (diabetes, hypertension) | Risk factors for ACE2 upregulation and worse immune dysregulation |

**High-Yield:** The elevated D-dimer and ferritin in this patient are hallmarks of the hyperinflammatory phase, not of bacterial superinfection (which would show elevated procalcitonin and positive blood/sputum cultures) or acute MI (which would show elevated troponin and ECG changes).

**Clinical Pearl:** Patients with severe COVID-19 who progress to ARDS typically require ICU admission, mechanical ventilation, and consideration of immunomodulatory therapy (corticosteroids, tocilizumab) to dampen the cytokine storm, not antibiotics alone.

[cite:Harrison 21e Ch 197]

Answer

A. Acute coronary syndrome secondary to myocardial infarction from plaque rupture

Answer

C. Bacterial superinfection of the lower respiratory tract causing acute bacterial pneumonia with sepsis

Answer

D. Pulmonary embolism from in-situ thrombosis alone without contribution from systemic inflammation

Explanation

Practice similar questions